| Financial Year |
March 31 2023 |
| Monetary Funds |
1,361,197,509.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
158,876.33 |
| Accounts Receivable |
132,373,057.52 |
| Advances to Suppliers |
23,752,426.69 |
| Other Receivables |
48,375,181.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
22,258,460.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,629,740.98 |
| Total Current Assets |
1,590,339,568.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,328,993.61 |
| Investment Properties |
10,872,838.57 |
| Fixed Assetes |
245,773,283.10 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
15,786,225.96 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
447,484,281.93 |
| Total Assets |
2,037,823,850.77 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
128,805,303.47 |
| Accounts Received In Advance |
177,692.16 |
| Employee Compensation Payable |
26,204,988.01 |
| Taxes Payable |
3,847,052.10 |
| Interest Payable |
-- |
| Dividend Payable |
10,529,140.48 |
| Other payables |
258,168,567.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,881,060.32 |
| Other Current Liabilities |
9,344,951.16 |
| Sub-Total of Current Liabilities |
497,938,625.35 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
140,596,492.13 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
158,427,899.91 |
| Total Liabilities |
656,366,525.26 |
| Paid-In Capital(Or Share Stock) |
631,052,069.00 |
| Capital Surplus |
1,665,572,649.36 |
| Surplus Reserve |
276,035,304.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,179,754,176.53 |
| Minority Stockholder's Interest |
-5,554,686.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,387,012,011.64 |
| Owner's Equity（Stockholder's Equity） |
1,381,457,325.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,037,823,850.77 |
